| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2024-09-10 18:57:45 UTC |
|---|
| Updated at | 2024-09-10 18:57:45 UTC |
|---|
| NP-MRD ID | NP0334573 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Pancreatin |
|---|
| Description | 9-Cis-Retinoic acid, also known as alitretinoin or aberel, belongs to the class of organic compounds known as retinoids. These are oxygenated derivatives of 3,7-dimethyl-1-(2,6,6-trimethylcyclohex-1-enyl)nona-1,3,5,7-tetraene and derivatives thereof. 9-Cis-Retinoic acid is a drug which is used for topical treatment of cutaneous lesions in patients with aids-related kaposi's sarcoma. 9-Cis-Retinoic acid is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Within humans, 9-cis-retinoic acid participates in a number of enzymatic reactions. In particular, 9-cis-retinoic acid can be biosynthesized from 9-cis-retinal through its interaction with the enzyme retinal dehydrogenase 1. In addition, 9-cis-retinoic acid can be biosynthesized from 9-cis-retinal through the action of the enzyme retinal dehydrogenase 2. In humans, 9-cis-retinoic acid is involved in retinol metabolism. 9-Cis-Retinoic acid is a potentially toxic compound. Pancreatin was first documented in 1997 (PMID: 9115228). A retinoic acid in which the exocyclic double bonds have 7E,9Z,11E,13E geometry (PMID: 10684759) (PMID: 11978340) (PMID: 12611604) (PMID: 12882648). |
|---|
| Structure | C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8-,16-14+ |
|---|
| Synonyms | | Value | Source |
|---|
| (2E,4E,6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid | ChEBI | | (7E,9Z,11E,13E)-Retinoic acid | ChEBI | | 9(Z)-Retinoic acid | ChEBI | | 9-cis-Tretinoin | ChEBI | | Alitretinoin | ChEBI | | Alitretinoina | ChEBI | | Alitretinoine | ChEBI | | Alitretinoinum | ChEBI | | Panretin | ChEBI | | Panretyn | ChEBI | | (2E,4E,6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate | Generator | | (7E,9Z,11E,13E)-Retinoate | Generator | | 9(Z)-Retinoate | Generator | | 9-cis-Retinoate | Generator | | 15-Apo-beta-caroten-15-Oate | HMDB | | 15-Apo-beta-caroten-15-Oic acid | HMDB | | 9-Retinoate | HMDB | | 9-Retinoic acid | HMDB | | Aberel | HMDB | | Aberela | HMDB | | Airol | HMDB | | Aknoten | HMDB | | all-trans- Vitamin a1 acid | HMDB | | all-trans-b-Retinoate | HMDB | | all-trans-b-Retinoic acid | HMDB | | all-trans-beta-Retinoate | HMDB | | all-trans-beta-Retinoic acid | HMDB | | all-trans-Vitamin a acid | HMDB | | alpha-Vitaminsyre | HMDB | | Atragen | HMDB | | Avita | HMDB | | Avitoin | HMDB | | b-Retinoate | HMDB | | b-Retinoic acid | HMDB | | beta-Retinoate | HMDB | | beta-Retinoic acid | HMDB | | Dermairol | HMDB | | Effederm | HMDB | | Epi-aberel | HMDB | | Eudyna | HMDB | | Isotretinoin retinoate | HMDB | | Isotretinoin retinoic acid | HMDB | | Panretin gel | HMDB | | Panrexin | HMDB | | Renova | HMDB | | Retacnyl | HMDB | | Retin a | HMDB | | Retin-a | HMDB | | Retin-a micro | HMDB | | Retinoate | HMDB | | Retinoic acid | HMDB | | Retinova | HMDB | | trans-Retinoate | HMDB | | trans-Retinoic acid | HMDB | | trans-Vitamin a acid | HMDB | | Tretinoin | HMDB | | Tretinoin/all-trans retinoate | HMDB | | Tretinoin/all-trans retinoic acid | HMDB | | Tretinon | HMDB | | Vesanoid | HMDB | | Vesnaroid | HMDB | | Toctino | HMDB | | 9CRA compound | HMDB | | 9 cis Retinoic acid | HMDB |
|
|---|
| Chemical Formula | C20H28O2 |
|---|
| Average Mass | 300.4351 Da |
|---|
| Monoisotopic Mass | 300.20893 Da |
|---|
| IUPAC Name | (2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid |
|---|
| Traditional Name | alitretinoin |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O |
|---|
| InChI Identifier | InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8-,16-14+ |
|---|
| InChI Key | SHGAZHPCJJPHSC-ZVCIMWCZSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| Not Available | | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as retinoids. These are oxygenated derivatives of 3,7-dimethyl-1-(2,6,6-trimethylcyclohex-1-enyl)nona-1,3,5,7-tetraene and derivatives thereof. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Prenol lipids |
|---|
| Sub Class | Retinoids |
|---|
| Direct Parent | Retinoids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Retinoic acid
- Diterpenoid
- Retinoid skeleton
- Medium-chain fatty acid
- Branched fatty acid
- Methyl-branched fatty acid
- Fatty acyl
- Unsaturated fatty acid
- Fatty acid
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organooxygen compound
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Aliphatic homomonocyclic compound
|
|---|
| Molecular Framework | Aliphatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Mertz JR, Shang E, Piantedosi R, Wei S, Wolgemuth DJ, Blaner WS: Identification and characterization of a stereospecific human enzyme that catalyzes 9-cis-retinol oxidation. A possible role in 9-cis-retinoic acid formation. J Biol Chem. 1997 May 2;272(18):11744-9. doi: 10.1074/jbc.272.18.11744. [PubMed:9115228 ]
- Hong SH, Mochizuki M, Nishimura R, Sasaki N, Kadosawa T, Matsunaga S: Differentiation induction of canine osteosarcoma cell lines by retinoids. Res Vet Sci. 2000 Feb;68(1):57-62. doi: 10.1053/rvsc.1999.0338. [PubMed:10684759 ]
- Serghides L, Kain KC: Mechanism of protection induced by vitamin A in falciparum malaria. Lancet. 2002 Apr 20;359(9315):1404-6. doi: 10.1016/S0140-6736(02)08360-5. [PubMed:11978340 ]
- Hidalgo CO, Diez C, Duque P, Facal N, Gomez E: Pregnancies and improved early embryonic development with bovine oocytes matured in vitro with 9-cis-retinoic acid. Reproduction. 2003 Mar;125(3):409-16. [PubMed:12611604 ]
- Antonio V, Janvier B, Brouillet A, Andreani M, Raymondjean M: Oxysterol and 9-cis-retinoic acid stimulate the group IIA secretory phospholipase A2 gene in rat smooth-muscle cells. Biochem J. 2003 Dec 1;376(Pt 2):351-60. doi: 10.1042/BJ20030098. [PubMed:12882648 ]
|
|---|